News

Making Artificial Intelligence Sustainable

SAIL is an interdisciplinary AI research network created by Bielefeld University, Paderborn University, Bielefeld University of Applied Sciences and OWL University of Applied Sciences and Arts funded by the state of North Rhine-Westphalia. SAIL addresses the next stage of AI development by looking at the entire life cycle of AI systems and their technological and societal impacts. The interdisciplinary research program brings together researchers from AI, engineering as well as the social sciences and humanities.

Lessons Learned from Global Vaccination Efforts

Redefining “Going Viral”

Look back at a year of vaccine news and check out the difference between press coverage on the pandemic in Germany and the U.S.

An Interview with Dr. Marie-Laure Yaspo

The Pros and Cons of Personalized Medicine

Dr. Marie-Laure Yaspo researches cancer genomics and systems biology of cancer as a Research Group Leader at the Max Planck Institute for Molecular Genetics. She is also Chief Science Officer at Alacris Theranostics, a European leader in comprehensive molecular tumor analysis. In an interview we chat about new developments in precision medicine, undercover cancer warriors and what life lessons cancer research might teach us.

mRNA Science and BioNTech

How a Once-Dismissed Idea Is Ending the Pandemic

BioNTech rose to global fame in 2020 for the successful COVID-19 vaccine they developed with Pfizer. But the vaccine is only the beginning for the German biotech. Their immunotherapy science may soon revolutionize medicine.

Hester Street

People-Focused City Building

When speaking of urban planning, many think of policymakers, architects and engineers. Hester Street, a nonprofit based is New York City, thinks of people. Their goal is to recenter urban planning, design and development on communities and residents, the people and places for which cities are built.

Schools and Universities Cautiously Reopen

The Challenges of Learning and the Pandemic

The struggles surrounding education and COVID-19 have been two-fold: first, schools and universities struggled to rapidly digitize education; now the same institutions are reckoning with how to safely reopen.

Pfizer and BioNTech Recruit for Large-Scale Vaccine Trial

Back in March we reported on vaccine developments by German biotechs CureVac and BioNTech. Four months later, clinical trials are underway. Together with Pfizer, BioNTech is rounding up participants for a COVID-19 vaccine trial in the U.S. Read on to find out how you can participate.